Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BAYER AG : Bernstein remains its Buy rating

05/13/2021 | 11:36am EDT

Bernstein analyst Gunther Zechmann maintains his Buy rating on the stock. The target price is unchanged and still at EUR 70.


ę MarketScreener with dpa-AFX Analyser 2021
All news about BAYER AG
06/18PRESS RELEASEá : BioNTech Announces First Patient Dosed in Phase 2 Clinical Tria..
DJ
06/18CureVac Could Allow Manufacturing Partners To Produce Rival Vaccines
MT
06/17SECTOR UPDATE : Health Care Stocks Add to Afternoon Gains
MT
06/17CureVac may let contractors make rival vaccines if own shot fails -CEO
RE
06/17SECTOR UPDATE : Health Care Stocks Maintaining Modest Thursday Advance
MT
06/17CureVac may let contractors make rival vaccines if own shot fails - CEO
RE
06/17CUREVAC Ná : Reports Disappointing Study Results for COVID-19 Vaccine, Driving S..
MT
06/17Bayer to Continue to Work With Curevac After Covid-19 Study Disappointment
DJ
06/16CUREVAC Ná : COVID-19 Vaccine Only 47% Effective in Mid-Stage Study
MT
06/16CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
RE
More news
Financials
Sales 2021 41 349 M 49 036 M 49 036 M
Net income 2021 3 593 M 4 261 M 4 261 M
Net Debt 2021 38 658 M 45 846 M 45 846 M
P/E ratio 2021 15,4x
Yield 2021 3,84%
Capitalization 51 823 M 61 438 M 61 458 M
EV / Sales 2021 2,19x
EV / Sales 2022 2,07x
Nbr of Employees 99 329
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 64,63 €
Last Close Price 52,75 €
Spread / Highest target 61,1%
Spread / Average Target 22,5%
Spread / Lowest Target -50,8%
EPS Revisions
Managers and Directors
NameTitle
Werner Baumann Chairman-Management Board
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG9.54%62 588
JOHNSON & JOHNSON2.92%435 090
ROCHE HOLDING AG12.75%328 768
PFIZER, INC.5.43%220 997
NOVARTIS AG2.73%210 424
ABBVIE INC.5.57%202 939